摘要
摘要：目的 观察欣母沛联合催产素用于有高危因素产后出血的临床效果。方法 选择 2018年 1月～ 2019年 6月我院收治的宫缩乏力引起的具有产后出血倾向的患者 152例，随机分为观察组和对照组各 76例，对照组采用催产素预防产后出血，观察组采用欣母沛联合催产素预防产后出血，比较两组治疗总有效率及产后 2h、 24h出血量。结果 观察组治疗总有效率明显高于对照组（ P<0.05）；观察组产后 2h、 24 h出血量均明显低于对照组（ P<0.05）。结论 欣母沛联合催产素预防产后出血效果明显。
关键词：欣母沛；催产素；产后出血；临床观察
Abstract: Objective To observe the clinical effect of xinmupei combined with oxytocin in postpartum hemorrhage with high risk factors. Methods from January 2018 to June 2019, 152 patients with postpartum hemorrhage tendency caused by uterine atony in our hospital were randomly divided into observation group and control group, 76 cases in each group. Oxytocin was used to prevent postpartum hemorrhage in the control group, and xinmupei combined with oxytocin was used to prevent postpartum hemorrhage in the observation group. The total effective rate and the amount of postpartum hemorrhage in 2H and 24h in the two groups were compared. Results the total effective rate of the observation group was significantly higher than that of the control group (P < 0.05), and the bleeding volume of the observation group at 2 and 24 hours after delivery was significantly lower than that of the control group (P < 0.05). Conclusion xinmupei combined with oxytocin is effective in preventing postpartum hemorrhage.
出版日期
2020年01月13日（中国期刊网平台首次上网日期，不代表论文的发表时间）
